The use of tissue-engineered skin (Apligraf) to treat a newborn with epidermolysis bullosa

Archives of Dermatology

Volumn 135, Issue 10, 1999, Pages 1219-1222

  Falabella, Anna F ^a,b   Schachner, Lawrence A ^a   Valencia, Isabel C ^a   Eaglstein, William H ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL SKIN; CASE REPORT; ELECTRON MICROSCOPY; EPIDERMOLYSIS BULLOSA; FEMALE; HUMAN; NEWBORN; PRIORITY JOURNAL; SKIN BIOPSY; WOUND DRESSING;

COLLAGEN; EPIDERMOLYSIS BULLOSA; FEMALE; HUMANS; INFANT, NEWBORN; SKIN, ARTIFICIAL;

EID: 0032745227     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.135.10.1219     Document Type: Article

References (22)

1. Fine JD. Epidermolysis bullosa. Dermatoepidemiology. 1995;13:659-670.
2. Fine JD, Resnick SD. Vesiculobullous and neonatal diseases. In: Pediatric Dermatology. 2nd ed. New York, NY: Churchill Livingstone Inc; 1995:767-809.
3. Fine JD, Bauer EA, Briggaman RA, et al. Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. J Am Acad Dematol. 1991;24: 119-135.
4. Stephens K, Sybert VP, Wijsman EM, et al. A keratin 14 mutational hot spot for epidermolysis bullosa simplex, Dowling-Meara: implication for diagnosis. J Invest Dermatol. 1993;101:240-243.
5. Ishida-Yamamoto A, McGrath JA, Chapman SJ, et al. Epidermolysis bullosa simplex (Dowling-Meara type) is a genetic disease characterized by an abnormal keratin-filament network involving keratins K5 and K14. J Invest Dermatol. 1991;97: 959-968.
6. Smith LT. Ultrastructural findings in epidermolysis bullosa. Arch Dermatol. 1993; 129:1578-1584.
7. Epstein EH. Molecular genetics of epidermolysis bullosa. Science. 1992;256: 799-804.
8. McGrath JA, Ishida-Yamamoto A, Tidman MJ, et al. Epidermolysis bullosa simplex (Dowling-Meara): a clinicopathological review. Br J Dermatol. 1992;126: 421-430.
9. Furumura M, Imayama S, Hori Y. Three neonatal cases of epidermolysis bullosa herpetiformis (Dowling-Meara type) with severe erosive skin lesions. J Am Acad Dermatol. 1993;28:859-861.
10. Buchbinder LH, Lucky AW, Ballard E, et al. Severe infantile epidermolysis bullosa simplex: Dowling-Meara type. Arch Dermatol. 1986;122:190-198.
11. Hashimoto I, Katabira Y, Mitsuhashi Y. PUVA therapy of epidermolysis bulosa herpetiformis Dowling-Meara and its influence on genetic counseling. Med Genet Res. 1983;5:150-156.
12. Bonnetblanc JM, Bouquier JJ. Response to pipamperone in a case of epidermolysis bullosa herpetiformis. Lancet. 1986;1:1327-1328.
13. Haber RM, Hanna W, Ramsay CA, et al. Hereditary epidermolysis bullosa. J Am Acad Dermatol. 1985;13:252-278.
14. Eaglstein WH, Falanga V. Tissue engineering and the development of Apligraf, a human skin equivalent. Adv Wound Care J Prev Healing. 1998;11:1-8.
15. Falanga V, Margolis D, Alvarez O, et al. Rapid healing of venous leg ulcers and lack of clinical rejection with an allogenic cultured human skin equivalent. Arch Dermatol. 1998;134:293-300.
16. Eaglstein WH, Iriondo M, Laszlo K. A composite skin substitute (Graftskin) for surgical wounds. Dermatol Surg. 1995;21:839-843.
17. Eisenberg M, Llewellyn DM, Moran K, Kerr A. Successful engraftment of cultured human epidermal allograft in a child with recessive dystrophic epidermolysis bullosa [letter]. Med J Aust. 1987;147:520-521.
18. Carter DM, Lin AN, Varghese MC, et al. Treatment of junctional epidermolysis bullosa with epidermal autografts. J Am Acad Dermatol. 1987;17:246-250.
19. McGrath JA, Schofield OM, Ishida-Yamamoto A, et al. Cultured keratinocyte allografts and wound healing in severe recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol. 1993;29:407-419.
20. Trent JF, Kirsner RS. Tissue engineered skin: Apligraf, a bi-layered living skin equivalent. Int J Clin Pract. 1998;52:408-413.
21. Navsaria HA, Myers SR, Leigh IM, et al. Culturing skin in vitro for wound therapy. Trends Biotechnol. 1995;13:91-99.
22. Alferink J, Tafuri A, Vestweber D, Hallmann R, Hämmerling GJ, Arnold B. Control of neonatal tolerance to tissue antigens by peripheral T cell trafficking. Science. 1998;232:1338-1341.